NYC stock · TECH stock

NYC vs TECH · $23.1M cap vs P/E 65, rev $1.22B

New York City REIT Inc (NYC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

New York City REIT Inc (NYC) is a real estate services company listed on NYSE.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported NYC revenue for 2024-12-31 was $0. Net income was -$140.6M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. NYC currently screens at market cap $23.1M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

NYC currently screens at market cap $23.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the NYC and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons